Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Allergen desensitization is a therapeutic approach that aims to induce long-term tolerance to specific allergens by gradually exposing the immune system to increasing doses of the allergen. This process shifts the immune response away from IgE-mediated hypersensitivity toward regulatory mechanisms, involving increased production of IgG4/IgA antibodies and the induction of regulatory T cells. Ultimately, this therapy reduces or eliminates allergic reactions upon subsequent allergen exposure.
Gradual exposure to allergens to induce tolerance by shifting the immune response from IgE-mediated hypersensitivity to IgG4/IgA production and promoting regulatory T cell activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Allergen Desensitization).